Posted On:Tuesday, May 29, 2018

workshop on Problems and Prospects for Commercialization of Trichoderma

A half day workshop on “Problems and Prospects for Commercialization of Trichoderma” was organized by ICAR-NBAIM on 24th May, 2018 at NASC Complex, New Delhi. Dr. Alok K. Srivastava, Principal Scientist ICAR-NBAIM welcomed the dignitaries and participants

Dr. T. Mohapatra, Secretary DARE and DG ICAR, New Delhi, in his inaugural address urged the ICAR institutes and other institutions working for biopesticide development with special reference to Trichoderma, to take appropriate interventions towards popularization of technology through the field application and demonstrations. He said strains specific to crop, disease or agroecological zone should be documented in the database and ICAR units should act as knowledge and resource centre for the technology, and should showcase the frontier technologies to the farmers. He further emphasized on developing molecular markers for tracking and diagnostics of Trichoderma strain and suggested that genomes of all the effective Trichoderma strains should be sequenced and cultures be deposited to ICAR-NBAIM.


Dr. Anil K. Saxena , Director, ICAR-NBAIM introduced the subject and emphasized that Pesticides based on microorganisms and their products have proven to be highly effective, species specific and eco-friendly in nature, leading to their adoption in pest management strategies around the world. However, the biopesticides represent only 4.2% of the overall pesticide market in India compared to 40% in USA and 20% each in Europe and Oceanic countries. Among the biofungicides, Trichoderma alone has a market share of 52.5%. In India, the demand for biopesticides is not uniform and highest demand for bio pesticides was observed from West India- Maharashtra followed by South India compared to other parts of the country and opened following issues for discussion in the forum.

· Do we have optimized protocols for development of formulations with enhanced shelf life and delivery system?

· Policy decision for pricing of microbes to be used as biopesticide. A clause on royalty to be added particularly for strains to be used for commercial production.

· How can the developmental cost and time to market be reduced? The Public- Private partnership appears to be a better solution.

Dr. A.N. Mukhopadhyay, Former VC AAU, Assam presented the history and progress of Trichoderma research in the country, followed by presentations of Dr. H.B. Singh, Professor, Instt. of Ag. Sciences BHU, Dr. M.S Rao, ICAR-IIHR and Dr. R.D. Prasad, ICAR-IIOR Hyderabad. Prof. K. Ramasamy, VC, TNAU and Dr. C. Manoharachary, Osmania University, Hyderabad and Dr. D.L.N. Rao, Scientist Emeritus, ICAR-IISS, Bhopal offered their comments and advised to develop a road map for commercialization of Trichoderma.

It was emphasized that the requirements of toxicological studies for CIB&RC registration needs to be relaxed and a single window system for toxicological studies, bioefficacy testing and finger printing may be evolved.

The Scientists from different ICAR Institutes, SAUs, entrepreneurs and industry personnel, and officials from ICAR HQ participated in the discussion session focused on prospects and problems in commercialization. Dr. Pawan K. Sharma, Principal Scientist ICAR-NBAIM proposed vote of thanks. More than 60 scientists and entrepreneurs participated in the worshop .